Lazard Asset Management
OXFD

Lazard Asset Management’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Lazard Asset Management’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,418
Closed -$44K – 1801
2020
Q2 		$44K Buy
+3,418
New +$41.1K ﹤0.01% 1263

Other funds holding OXFD

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Lazard Asset Management's OXFD Position: Q3 2020 in Review

Lazard Asset Management sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q3 2020, closing a stake of 3,418 shares — an estimated $44K sold.

Lazard Asset Management first reported a position in OXFD in Q2 2020 and held it in 1 quarter. The position peaked at $44K in Q2 2020. 71 funds tracked by Wall St. Rank hold OXFD as of Q3 2020.

  • Lazard Asset Management reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q3 2020 after selling out during the quarter.
  • Lazard Asset Management sold 3,418 Oxford Immunotec Global PLC Ordinary Shares shares in Q3 2020, an estimated $44K.
  • Lazard Asset Management first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q2 2020 and held it in 1 quarter.
  • Lazard Asset Management's Oxford Immunotec Global PLC Ordinary Shares position peaked at $44K in Q2 2020.
  • 71 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q3 2020.

Based on Lazard Asset Management's 13F filing for Q3 2020, filed 13 Nov 2020.